Emerging Companies in the Vietnam Donepezil Market | Competitive Landscape 2026

Vietnam Donepezil Market Overview

According to 6Wresearch, the Vietnam Donepezil market is estimated to rise, owing to the rising prevalence of age-related cognitive disorders, and the growing focus on geriatric mental health services. Donepezil is considered a first line pharmacological treatment, used to improve cognitive function, memory retention, and behavioural stability for Alzheimer's type dementia. The market growth is supported by the advancement of healthcare infrastructure, that highlights the importance of neurodegenerative care, with specialized clinics and hospital wards integrating Donepezil into standard long-term care programs. Domestic production capacity is increasingly oriented towards high-bioavailability oral formulations to ensure that advanced therapeutic options are easily accessible.

Competitive Landscape

The competitive landscape of the Vietnam Donepezil Industry is composed of domestic pharmaceutical leaders and international partnerships. Leading companies are focusing on rigorous quality control, to ensure consistent efficacy of the neurotransmitter-modulating compounds. Additionally, the growing concern of manufacturers is patient compliance, which leads to the introduction of advanced coating technologies, to minimize gastrointestinal side effects.

Below is a list of leading players operating in the Vietnam Donepezil Market:

1. DHG Pharmaceutical Joint Stock Company

DHG Pharma maintains a robust portfolio of neuro-focused essential medicines, ensuring widespread distribution of high-quality cognitive enhancers.

2. Traphaco Joint Stock Company

Traphaco leverages its advanced research capabilities to provide reliable Donepezil-based therapies, emphasizing safety and efficacy for geriatric health programs.

3. Imexpharm Pharmaceutical Joint Stock Company

Imexpharm operates EU-GMP compliant facilities, focusing on the production of medical-grade cognitive medications that meet international standards.

4. Pymepharco Joint Stock Company (STADA Group)

Pymepharco provides sophisticated Donepezil formulations designed to improve long-term adherence in Alzheimer's care.

5. Mekophar Chemical Pharmaceutical JSC

Mekophar serves as a vital supplier for hospital-based procurement, focusing on the accessibility and affordability of essential anti-dementia medications.

6. Domesco Medical Import Export JSC

Domesco specializes in the domestic manufacturing and import of specialized pharmaceutical treatments, playing a key role in the CNS medication supply chain.

7. Bidiphar (Binh Dinh Pharmaceutical and Medical Equipment JSC)

Bidiphar contributes significantly to the neurological health sector by producing high-purity medications used in specialized geriatric facilities.

8. OPC Pharmaceutical Joint Stock Company

OPC focuses on pharmaceutical-grade cognitive support, ensuring that Donepezil formulations are readily available for specialized neuro-rehabilitation clinics.

9. Cuu Long Pharmaceutical JSC

DCL is a strategic manufacturer providing vital neurological health medications that support the increasing demand for Alzheimer's symptom management.

10. Ha Tay Pharmaceutical JSC (Hataphar)

Hataphar focuses on essential neuro-active pharmaceutical supplies required for long-term cognitive care programs.